Advancing health through connecting science

 

BUFFALO GROVE (IL, USA), GRONINGEN (The Netherlands), OSS (The Netherlands) – Austin Chemical Company Inc, a pharmaceutical procurement and logistics service provider announced today the joint venture with Syncom BV, a pharmaceutical contract synthesis company.

The development of novel active pharmaceutical ingredients (NCEs, APIs) demands a broad range of specialized technologies that should be combined to enable the shortest development time to clinical evaluation. The SynConnection companies, each building upon decades of pharmaceutical development history, join forces providing optimal chemical contract development services for small- and mid-sized pharma and biotech companies. SynConnection offers specialized IND/IMPD enabling technologies including chiral resolution and process development, GMP manufacturing of highly potent materials, complex purifications, analytical development and validation, nanomedicines manufacturing, as well as global logistics and procurement.

Sam Ponticelli, CEO of Austin Chemical Company, commented: “We are very pleased with this exciting cooperation. This joint venture officially connects decades of pharmaceutical development history”

Ton Vries, CEO of Syncom, commented: “For Syncom this joint venture is a tremendous step forward. Syncom has been working with leading pharmaceutical and biotech companies around the world and has established a solid name in the preclinical pharmaceutical contract synthesis market. Joining forces with Austin Chemical now adds specialized GMP manufacturing services and knowledge to our portfolio. The SynConnection cooperation will give us the opportunity to further assist our customers with developing their pipeline.”

About Austin Chemical Company Inc

Austin, founded in 1976, is based in the US with branch offices in China, India, and Switzerland. As an originator of Sourcing & Procurement services Austin has provided over 6,000 raw materials, intermediates, fine chemicals, and active substance (APIs).  That, as well as expertise in logistics and international business dealings allows Austin to seamlessly transport product worldwide. Partners such as Syncom allow Austin to be a strategic source of both cGMP and non cGMP manufacturing capabilities, raw materials, intermediates and APIs.

 About Syncom BV

Syncom is a global leader in providing pharmaceutical industry with custom synthesis solutions. Established in 1988, Syncom has built an excellent track record working for leading global pharmaceutical enterprises and emerging biotech companies. The highly educated and experienced Syncom team of 110 FTE, is dedicated to developing novel chemical processes and synthesizing impurities, metabolites and reference materials. Besides knowledge in the field of classical resolution, Syncom offers a broad range of chiral technologies. Syncom is the inventor of the highly effective resolution variant known as Dutch Resolution.